Advocacy intelligence hub — real-time data for patient organizations
Eye & ENT Hospital of Fudan University — NA
Edward Wood, MD — PHASE4
Jaeb Center for Health Research — PHASE3
David Nashaat Shafik Fahmy — NA
University Hospital, Basel, Switzerland — PHASE1
Fundacion Clinic per a la Recerca Biomédica — PHASE2
Health Poverty Action — NA
Li Xiaorong — EARLY_PHASE1
Swiss Tropical & Public Health Institute — NA
New York Stem Cell Foundation Research Institute — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
CARBIDOPA, LEVODOPA, AND ENTACAPONE
Sandoz Inc
DHIVY
(CARBIDOPA LEVODOPA)standardAvion Pharmaceuticals, LLC
Aromatic Amino Acid Decarboxylation Inhibitor [EPC]
Peiquan Zhao
Xinhua Hospital affiliated with Shanghai Jiao Tong UniversitySchool of Medicine
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
📍 Bethesda, Maryland
Laura Andres-Martin
The New York Stem Cell Foundation Research Institute
📍 New York, New York
Michele Matarazzo, MD
Oregon Health & Science University
📍 Portland, Oregon
Anna S Vergmann
Odense University Hospital
Veronique Vanderhorst, MD PhD
Clinical Research Center BIDMC
📍 Boston, Massachusetts
View all X-linked reticulate pigmentary disorder specialists →